Peggy Rentsch

UNSW Sydney — Australia

Medicine · Health Sciences

6h-index153citations19works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(5), Neuroinflammation and Neurodegeneration Mechanisms(5), Neuroscience and Neuropharmacology Research(3), Alzheimer's disease research and treatments(3), Nerve injury and regeneration(3)

Publications19 total

Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway
Scientific Reports·2026Open Access
Renal and hepatic function is preserved following inducible knockout of kynurenine pathway enzymes KMO or QPRT in adult mice
PLoS ONE·2025Open Access
Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters
Frontiers in Pharmacology·2025Open Access
Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway
2025Open Access
Toward the development of a sporadic model of Alzheimer's disease: comparing pathologies between humanized APP and the familial J20 mouse models
Frontiers in Aging Neuroscience·2024· 1 citedOpen Access
Modeling sporadic Alzheimer’s disease in mice by combining Apolipoprotein E4 risk gene with environmental risk factors
Frontiers in Aging Neuroscience·2024· 6 citedOpen Access
Quantification of AMPA receptor subunits and RNA editing-related proteins in the J20 mouse model of Alzheimer’s disease by capillary western blotting
Frontiers in Molecular Neuroscience·2024· 2 citedOpen Access
The ratio of <scp>M1</scp> to <scp>M2</scp> microglia in the striatum determines the severity of <scp>L‐Dopa</scp> ‐induced dyskinesias
Journal of Neurochemistry·2023· 9 citedOpen Access
Author response for "The ratio of &lt;scp&gt;M1&lt;/scp&gt; to &lt;scp&gt;M2&lt;/scp&gt; microglia in the striatum determines the severity of &lt;scp&gt;L‐Dopa&lt;/scp&gt;‐induced dyskinesias"
2023
Author response for "The ratio of &lt;scp&gt;M1&lt;/scp&gt; to &lt;scp&gt;M2&lt;/scp&gt; microglia in the striatum determines the severity of &lt;scp&gt;L‐Dopa&lt;/scp&gt;‐induced dyskinesias"
2023
Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia
Neurobiology of Disease·2019· 33 citedOpen Access
The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain
Experimental Neurology·2019· 19 cited
Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia
BMC Neuroscience·2019· 44 citedOpen Access
MOESM1 of Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia
Figshare·2019Open Access
Activin A protects nigral neurons against MPTP-induced cell death.
Figshare·2017Open Access
Activin A alters TH phosphorylation but not striatal DAT following MPTP.
Figshare·2017Open Access
Activin A protects midbrain neurons up to 8 weeks post-MPTP.
Figshare·2017Open Access
Activin A Inhibits MPTP and LPS-Induced Increases in Inflammatory Cell Populations and Loss of Dopamine Neurons in the Mouse Midbrain In Vivo
PLoS ONE·2017· 21 citedOpen Access
Activin A Protects Midbrain Neurons in the 6-Hydroxydopamine Mouse Model of Parkinson’s Disease
PLoS ONE·2015· 18 citedOpen Access

Frequent Co-authors

Bryce Vissel(19), Sandy Stayte(15), Timothy Egan(4), Bamberger Maximilian(4), Gary P. Morris(3), Kong M. Li(3), Luke T. Milham(3), Tröscher Anna R.(3), M. Li Kong(3), Kathryn J. Laloli(2), Kiruthika Ganesan(2), Alexander Langdon(2), Lyndsey M. Konen(2), G Federici(2), Ian A. Clark(1), Anna R. Tröscher(1), Aimee Lowth(1), Russell Pickford(1), Nesli Avgan(1), Benjamin S. Summers(1)